| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |